Structure Therapeutics (GPCR) Institutional Ownership → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free GPCR Stock Alerts $35.88 -0.19 (-0.53%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Structure Therapeutics (NASDAQ:GPCR)CurrentInstitutional OwnershipPercentage91.78%Number ofInstitutional Buyers(last 12 months)51TotalInstitutional Inflows(last 12 months)$828.33MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$104.53M Get GPCR Insider Trade Alerts Want to know when executives and insiders are buying or selling Structure Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GPCR Institutional Buying and Selling by Quarter Ad Paradigm PressBiden FINISHED On June 13th?Thanks to Biden’s disgraceful leadership we now have sky-high inflation… unchecked immigration… rampant crime… and a “woke mob” hell bent on destroying the America you and I know and love. Biden’s days are numbered.Click here now to see his shocking evidence. Structure Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 Janus Henderson Group PLC2,076,700$88.99M0.0%+34.5%4.455% 5/15/2024 First Light Asset Management LLC149,113$6.39M0.5%N/A0.320% 5/15/2024 Bellevue Group AG363,926$15.60M0.2%+2,858.7%0.781% 5/15/2024 Price T Rowe Associates Inc. MD1,560,950$66.90M0.0%-7.1%3.348% 5/15/2024 Altitude Crest Partners Inc.205,166$8.79M3.8%N/A0.440% 5/14/2024 Capital Research Global Investors1,527,483$65.47M0.0%+56.9%3.276% Get the Latest News and Ratings for GPCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Structure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/14/2024 Capital International Investors1,281,564$54.93M0.0%+50.8%2.749% 5/8/2024 Russell Investments Group Ltd.21,712$931K0.0%-23.5%0.047% 5/2/2024 FORA Capital LLC17,090$732K0.1%N/A0.037% 4/29/2024 China Universal Asset Management Co. Ltd.9,376$402K0.1%+115.6%0.020% 4/18/2024 Allspring Global Investments Holdings LLC47,269$2.03M0.0%-1.7%0.101% 4/15/2024 TrueMark Investments LLC29,884$1.28M1.2%+13.5%0.064% 3/5/2024 Wellington Management Group LLP4,372,326$178.22M0.0%+404.0%9.426% 3/1/2024 Goldman Sachs Group Inc.427,735$17.43M0.0%+498.8%0.922% 2/15/2024 Octagon Capital Advisors LP414,000$16.88M2.7%N/A0.893% 2/15/2024 Parkman Healthcare Partners LLC38,678$1.58M0.2%+28.9%0.083% 2/15/2024 Frazier Life Sciences Management L.P.317,190$12.93M0.7%N/A0.684% 2/15/2024 Brandywine Managers LLC12,007$489K0.5%+9.2%0.026% 2/15/2024 BVF Inc. IL812,988$33.14M0.8%-53.5%1.753% 2/15/2024 Boxer Capital LLC400,000$16.30M0.8%N/A0.862% 2/14/2024 ADAR1 Capital Management LLC4,000$163K0.1%N/A0.009% 2/14/2024 Braidwell LP280,158$11.42M0.4%N/A0.604% 2/14/2024 Bellevue Group AG12,300$501K0.0%-26.8%0.027% 2/14/2024 Avoro Capital Advisors LLC2,333,333$95.11M1.3%+133.3%5.030% 2/14/2024 Platinum Investment Management Ltd.77,093$3.14M0.1%+47.0%0.166% 2/14/2024 Sectoral Asset Management Inc.3,400$139K0.1%N/A0.007% 2/13/2024 Capital World Investors634,160$25.85M0.0%+531.6%1.367% 2/13/2024 Capital Research Global Investors973,535$39.68M0.0%+182.3%2.099% 2/13/2024 Capital International Investors850,024$34.65M0.0%N/A1.832% 2/12/2024 Monashee Investment Management LLC191,855$7.82M1.4%-69.7%0.414% 2/12/2024 TD Asset Management Inc157,258$6.41M0.0%+3.3%0.339% 2/9/2024 Franklin Resources Inc.542,323$22.11M0.0%+116.2%1.169% 2/8/2024 EFG Asset Management North America Corp.17,390$705K0.1%N/A0.037% 2/7/2024 E Fund Management Co. Ltd.28,589$1.17M0.1%N/A0.062% 2/6/2024 M&T Bank Corp14,600$596K0.0%N/A0.031% 2/6/2024 Natixis Advisors L.P.15,558$634K0.0%N/A0.034% 2/5/2024 Victory Capital Management Inc.125,447$5.11M0.0%-16.9%0.270% 2/5/2024 Russell Investments Group Ltd.28,393$1.16M0.0%N/A0.061% 2/1/2024 New York State Common Retirement Fund6,800$277K0.0%N/A0.015% 1/31/2024 Federated Hermes Inc.2,267,206$92.41M0.2%+104.2%4.887% Biden FINISHED On June 13th? (Ad)Thanks to Biden’s disgraceful leadership we now have sky-high inflation… unchecked immigration… rampant crime… and a “woke mob” hell bent on destroying the America you and I know and love. Biden’s days are numbered.Click here now to see his shocking evidence.1/25/2024 Allspring Global Investments Holdings LLC48,085$1.96M0.0%N/A0.104% 1/24/2024 China Universal Asset Management Co. Ltd.4,349$177K0.0%+208.4%0.009% 1/16/2024 Raymond James & Associates5,705$233K0.0%N/A0.012% 1/11/2024 TrueMark Investments LLC26,322$1.07M1.1%N/A0.057% 12/1/2023 Wellington Management Group LLP867,579$43.74M0.0%+312.6%1.870% 11/15/2023 Acuta Capital Partners LLC5,000$252K0.2%N/A0.013% 11/15/2023 Adage Capital Partners GP L.L.C.1,799,923$90.75M0.2%+835.5%4.703% 11/14/2023 MPM Bioimpact LLC230,761$11.64M3.1%N/A0.603% 11/14/2023 Schonfeld Strategic Advisors LLC24,600$1.24M0.0%N/A0.064% 11/14/2023 Fred Alger Management LLC99,340$5.01M0.0%+845.0%0.260% 11/14/2023 Avidity Partners Management LP500,000$25.21M1.0%+1,222.8%1.307% 11/14/2023 Monashee Investment Management LLC633,766$31.95M13.3%-53.8%1.656% 11/13/2023 EAM Investors LLC43,978$2.22M0.4%N/A0.115% 11/13/2023 Federated Hermes Inc.1,110,200$55.98M0.1%+9.4%2.901% 11/13/2023 FMR LLC1,590,335$80.19M0.0%+28.5%4.156% 11/13/2023 Maven Securities LTD22,500$1.13M0.0%-10.0%0.059% 11/9/2023 Washington University4,274$215K0.1%N/A0.011% 11/7/2023 Virtus ETF Advisers LLC3,194$161K0.1%-9.1%0.008% 11/7/2023 Barclays PLC5,832$294K0.0%+415.2%0.015% 11/6/2023 Picton Mahoney Asset Management2,320$116K0.0%N/A0.006% 11/6/2023 Victory Capital Management Inc.150,958$7.61M0.0%N/A0.394% 11/3/2023 Platinum Investment Management Ltd.52,461$2.65M0.1%+249.7%0.137% 10/31/2023 Jennison Associates LLC420,479$21.20M0.0%+5.2%1.099% 10/31/2023 China Universal Asset Management Co. Ltd.1,410$71K0.0%-94.8%0.004% 10/27/2023 TD Asset Management Inc152,176$7.67M0.0%+109.3%0.398% 9/21/2023 Barclays PLC1,132$47K0.0%N/A0.003% 8/14/2023 Casdin Capital LLC997,017$41.45M3.6%+47.3%2.605% 8/14/2023 Driehaus Capital Management LLC1,135,936$47.22M0.6%+20.8%2.968% 8/11/2023 Franklin Resources Inc.250,809$10.43M0.0%-22.8%0.655% 8/10/2023 Monashee Investment Management LLC1,370,991$22.76M5.4%+706.5%3.583% 8/9/2023 TD Asset Management Inc72,709$3.02M0.0%+102.3%0.190% 8/4/2023 Maven Securities LTD25,000$1.04M0.0%N/A0.065% 7/28/2023 China Universal Asset Management Co. Ltd.27,267$1.13M0.3%N/A0.076% 5/16/2023 BVF Inc. IL1,750,000$41.63M1.5%N/A4.783% 5/15/2023 Logos Global Management LP350,000$8.33M1.2%N/A0.957% 5/12/2023 Platinum Investment Management Ltd.15,000$357K0.0%N/A0.041% 5/8/2023 Federated Hermes Inc.1,052,802$25.05M0.1%N/A2.877% 5/5/2023 Monashee Investment Management LLC170,000$4.04M1.1%N/A0.465% (Data available from 1/1/2016 forward) GPCR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GPCR shares? During the previous two years, 54 institutional investors and hedge funds held shares of Structure Therapeutics. The most heavily invested institutionals were Wellington Management Group LLP ($178.22M), Avoro Capital Advisors LLC ($95.11M), Federated Hermes Inc. ($92.41M), Adage Capital Partners GP L.L.C. ($90.75M), Janus Henderson Group PLC ($88.99M), FMR LLC ($80.19M), and Price T Rowe Associates Inc. MD ($66.90M).Learn more on GPCR's institutional investors. What percentage of Structure Therapeutics stock is owned by institutional investors? 91.78% of Structure Therapeutics stock is owned by institutional investors. Learn more on GPCR's institutional investor holdings. Which institutional investors have been buying Structure Therapeutics stock? Of the 52 institutional investors that purchased Structure Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Wellington Management Group LLP ($4.16M), Federated Hermes Inc. ($2.31M), BVF Inc. IL ($1.75M), Adage Capital Partners GP L.L.C. ($1.61M), Monashee Investment Management LLC ($1.37M), Avoro Capital Advisors LLC ($1.33M), and Capital International Investors ($1.28M). How much institutional buying is happening at Structure Therapeutics? Institutional investors have bought a total of 21,570,090 shares in the last 24 months. This purchase volume represents approximately $866.11M in transactions. Which Structure Therapeutics major shareholders have been selling company stock? Of the 11 institutional investors that sold Structure Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Monashee Investment Management LLC ($1.18M), BVF Inc. IL ($937.01K), Price T Rowe Associates Inc. MD ($118.49K), Franklin Resources Inc. ($74.19K), China Universal Asset Management Co. Ltd. ($25.86K), Victory Capital Management Inc. ($25.51K), and Russell Investments Group Ltd. ($6.68K). How much institutional selling is happening at Structure Therapeutics? Institutional investors have sold a total of 2,375,009 shares in the last 24 months. This volume of shares sold represents approximately $104.53M in transactions. Related Companies: Schrödinger Major Shareholders Harmony Biosciences Major Shareholders Edgewise Therapeutics Major Shareholders Kura Oncology Major Shareholders Supernus Pharmaceuticals Major Shareholders Protagonist Therapeutics Major Shareholders Taro Pharmaceutical Industries Major Shareholders Arcus Biosciences Major Shareholders Ligand Pharmaceuticals Major Shareholders Ardelyx Major Shareholders This page (NASDAQ:GPCR) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersBiden FINISHED On June 13th?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe #1 Investment of the Decade… Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Nvidia WarningAltimetryThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.